MicroVision, Inc. (MVIS) Trades Expensive While Bristol-Myers Squibb Company (BMY) Is Underpriced – Post Analyst

This post was originally published on this site

MicroVision, Inc. (MVIS) Trades Expensive While Bristol-Myers Squibb Company (BMY) Is Underpriced  Post Analyst

MicroVision, Inc. (NASDAQ:MVIS) is simply too expensive to pass with a price-to-sales ratio of 5.42. The competitors from Diversified Electronics hold an …

This post was originally published on *this site*